A Phase II Study of the Docetaxel- Ifosfamide-Carboplatin Combination in Advanced Non-Small-Cell Lung Cancer

Publisher： Karger

E-ISSN： 1423-0232|69|4|333-341

ISSN： 0030-2414

Source： Oncology, Vol.69, Iss.4, 2005-12, pp. : 333-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paclitaxel, Carboplatin, and G-CSF in Advanced Non-Small-Cell Lung Cancer: A Phase I/II Study

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1998-09 ,pp. : 310-314

Karger

Access to resources Recommend Favorite

Phase II Study of First-Line Sequential Chemotherapy with Gemcitabine-Carboplatin Followed by Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 382-390

Karger

Access to resources Recommend Favorite

Phase II Study of Irinotecan and Ifosfamide in Patients with Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 306-311

Karger

Access to resources Recommend Favorite

A Randomized Phase II Study Comparing Two Schedules of the 21-Day Regimen of Gemcitabine and Carboplatin in Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 78, Iss. 3-4, 2010-06 ,pp. : 267-270

Karger

Access to resources Recommend Favorite

Phase I Study of Cisplatin, Ifosfamide and Irinotecan with rhG-CSF Support in Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 56, Iss. 4, 1999-05 ,pp. : 301-307

Karger

Access to resources Recommend Favorite